Request more information about how Myriad’s prenatal screening options can benefit your patients.
Fetal fraction plays an important role in delivering prenatal cell-free DNA (cfDNA) screening results to your patients. Low fetal fraction, which is more prevalent among patients that present with high BMI, can cause sample failure. Prequel with AMPLIFY technology enriches fetal fraction to deliver results to 99.9% of ALL patients, even those with high BMI.
Schedule an appointment with your Prequel representative to learn more about:
AMPLIFY enriches fetal fraction for every single patient so you can have more confidence in the results while reducing repeat tests.
Myriad Genetics provides affordable access to prenatal genetic screening through financial assistance programs for qualified patients.
Myriad offers you and your patients on-demand access to board-certified genetic counselors for pre- and post-test education.
To schedule an appointment, please fill out the form.
Use this slider to see for yourself how Prequel with AMPLIFY technology more than doubles the fetal fraction for all patients. Notice that patients with less than 4% fetal fraction who may have experienced a sample failure, received a result with Prequel.
Hear how non-invasive prenatal screening provided early insights into Hannah’s pregnancy and helped their family plan and prepare.
of female patients present with high BMI1
Patients with high BMI may have lower fetal fraction in prenatal cfDNA screening2
of cfDNA non-invasive prenatal screen failures are due to reduced fetal fraction3
Sample failures may mean:4,5